OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 29 of 45

30 Assessment/Diagnosis   ➤ Diagnostic Criteria • The diagnosis of OSA is established through objective sleep testing, with polysomnography serving as the gold standard for measuring the apnea-hypopnea index. Home sleep apnea testing is suitable for certain uncomplicated cases. The apnea-hypopnea index defines OSA severity as mild (5–14.9 events/h), moderate (15–29.9 events/h), and severe (≥30 events/h). Clinical symptoms, such as excessive sleepiness and hypertension, are integrated with apnea-hypopnea index values to inform treatment decisions. Although emerging biomarkers, such as adipokine profiles, are being studied, they are not yet part of standard diagnostic practice. Gastroesophageal Reflux Disease   ➤ In the presence of obesity, GERD arises from visceral adiposity- induced intraabdominal pressure that disrupts lower esophageal sphincter function and esophagogastric anatomy (often worsened by hiatal hernia). Hormonal and inflammatory disturbances further impair mucosal defenses, leading to increased esophageal injury even in the absence of typical symptoms. Risk Factors • Central adiposity, as measured by waist-to-hip ratio, is a stronger predictor of GERD than BMI, with each 3.5 kg/m² increase in BMI associated with a 2.7-fold increase in risk. Modif iable contributors include dietary habits, particularly high intake of ultra-processed fats and ref ined carbohydrates, which reduce lower esophageal sphincter pressure and delay gastric emptying; lifestyle factors such as smoking, alcohol consumption, and late-night eating; the use of certain medications (e.g., nonsteroidal anti-inflammatory drugs, nitrates, glucagon-like peptide-1 receptor agonists, and some calcium channel blockers); and sleeve gastrectomy. Nonmodif iable risks include male sex and postmenopausal status, attributed to hormonal changes and central fat distribution, genetic predisposition, including familial clustering of hiatal hernia and higher prevalence in White populations, and craniofacial structural abnormalities like retrognathia, which can impair esophagogastric junction function.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026